The Phenomenon of Albumin-Mediated Hepatic Uptake of Organic Anion Transport Polypeptide Substrates: Prediction of the In Vivo Uptake Clearance from the In Vitro Uptake by Isolated Hepatocytes Using a Facilitated-Dissociation Model

The effects of bovine serum albumin and human serum albumin on the unbound hepatic uptake clearance (PSu,inf) of the organic anion–transporting polypeptide substrates 1-anilino-8-naphthalene sulfonate (ANS) and pitavastatin (PTV) were determined using primary cultured rat hepatocytes and isolated human hepatocytes, respectively. The PSu,inf value of hepatocytes was estimated by dividing the initial uptake rate of these anions by their unbound concentrations. The PSu,inf values for ANS and PTV were enhanced in the presence of albumin, thereby demonstrating the phenomenon of “albumin-mediated” hepatic uptake. We previously constructed a “facilitated-dissociation” model, in which the interaction of the ligand-albumin complex with the cell surface enhanced the dissociation of that complex to provide unbound ligand for uptake to the hepatocytes [J Pharmacokinet Biopharm 16:165–181 (1988)]. That model was able to describe accurately the relationship between the enhancement of the PSu,inf values and the albumin concentration. By considering the enhancement of hepatic uptake clearance by albumin using this facilitated-dissociation model, we could predict accurately the PSu,inf in vivo from that obtained in isolated hepatocytes. In the light of these findings, we suggest that the facilitated-dissociation model is applicable to describing the phenomenon of albumin-mediated hepatic uptake via organic anion transporters and to evaluating hepatic uptake clearance in vivo.

[1]  B. Luxon,et al.  Albumin helps mediate removal of taurocholate by rat liver. , 1981, The Journal of clinical investigation.

[2]  Kazuya Maeda,et al.  Investigation of the Rate-Determining Process in the Hepatic Elimination of HMG-CoA Reductase Inhibitors in Rats and Humans , 2010, Drug Metabolism and Disposition.

[3]  S. Miyauchi,et al.  Electrophysiological characterization of human Na⁺/taurocholate cotransporting polypeptide (hNTCP) heterologously expressed in Xenopus laevis oocytes. , 2014, Archives of biochemistry and biophysics.

[4]  S. Haddad,et al.  Albumin and Uptake of Drugs in Cells: Additional Validation Exercises of a Recently Published Equation that Quantifies the Albumin-Facilitated Uptake Mechanism(s) in Physiologically Based Pharmacokinetic and Pharmacodynamic Modeling Research. , 2015, Journal of pharmaceutical sciences.

[5]  S. Pond,et al.  The Puzzle of Rates of Cellular Uptake of Protein-Bound Ligands , 1988 .

[6]  Y. Sawada,et al.  Protein-mediated hepatic uptake of rose bengal in analbuminemic mutant rats (NAR). Albumin is not indispensable to the protein-mediated transport of rose bengal. , 1988, Drug metabolism and disposition: the biological fate of chemicals.

[7]  F. Burczynski,et al.  Palmitate uptake by cultured hepatocytes: albumin binding and stagnant layer phenomena. , 1989, The American journal of physiology.

[8]  G. Wilkinson,et al.  Perfusion-limited effects of plasma drug binding on hepatic drug extraction , 1976 .

[9]  Y. Sugiyama,et al.  Kinetic analysis of albumin-mediated uptake of warfarin by perfused rat liver , 1988, Journal of Pharmacokinetics and Biopharmaceutics.

[10]  S. Haddad,et al.  Predictions of bisphenol A hepatic clearance in the isolated perfused rat liver (IPRL): impact of albumin binding and of co-administration with naproxen , 2018, Xenobiotica; the fate of foreign compounds in biological systems.

[11]  S. Haddad,et al.  Comparative assessment of In Vitro-In Vivo extrapolation methods used for predicting hepatic metabolic clearance of drugs. , 2012, Journal of pharmaceutical sciences.

[12]  B. Luxon,et al.  Effect of albumin binding on the hepatic transport of rose bengal: surface-mediated dissociation of limited capacity. , 1982, The Journal of pharmacology and experimental therapeutics.

[13]  Frank J Burczynski,et al.  The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research. , 2016, Journal of pharmaceutical sciences.

[14]  Michael S. Roberts,et al.  A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations , 1986, Journal of Pharmacokinetics and Biopharmaceutics.

[15]  Y. Sugiyama,et al.  Kinetic analysis of the dose-dependent hepatic handling of 1-anilino-8-naphthalene sulfonate in rats , 1990, Journal of Pharmacokinetics and Biopharmaceutics.

[16]  J. Lin,et al.  Effects of organic anions on the uptake of 1-anilino-8-naphthalenesulfonate by isolated liver cells. , 1983, Journal of pharmaceutical sciences.

[17]  R. Weisiger Dissociation from albumin: a potentially rate-limiting step in the clearance of substances by the liver. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Gollan,et al.  Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances. , 1981, Science.

[19]  S. Pond,et al.  Hepatic uptake of protein-bound ligands: extended sinusoidal perfusion model. , 1991, The American journal of physiology.

[20]  L. Gustavsson,et al.  Effect of cryopreservation on the activity of OATP1B1/3 and OCT1 in isolated human hepatocytes. , 2011, Chemico-biological interactions.

[21]  B. Blitzer,et al.  Enhancement of Na+-dependent bile acid uptake by albumin: direct demonstration in rat basolateral liver plasma membrane vesicles. , 1985, The American journal of physiology.

[22]  P. Sluijs,et al.  Lactosylation of albumin reduces uptake rate of dibromosulfophthalein in perfused rat liver and dissociation rate from albumin In Vitro , 1987, Hepatology.

[23]  K. Maeda,et al.  Characterization of organic anion transporting polypeptide (OATP) expression and its functional contribution to the uptake of substrates in human hepatocytes. , 2012, Molecular pharmaceutics.

[24]  B. Luxon,et al.  Albumin-mediated transport of rose bengal by perfused rat liver. Kinetics of the reaction at the cell surface. , 1983, The Journal of clinical investigation.

[25]  T. Iga,et al.  Effect of various organic anions on the plasma disappearance of 1-anilino-8-naphthalene sulfonate. , 1990, Journal of hepatology.

[26]  T. Horie,et al.  Conformational change in plasma albumin due to interaction with isolated rat hepatocyte. , 1988, The American journal of physiology.

[27]  G. Wilkinson,et al.  Perfusion-limited of plasma drug binding on hepatic drug extraction. , 1976, Life sciences.

[28]  Y. Sugiyama,et al.  Comparison of the Hepatic Uptake Clearances of Fifteen Drugs with a Wide Range of Membrane Permeabilities in Isolated Rat Hepatocytes and Perfused Rat Livers , 1993, Pharmaceutical Research.

[29]  G R Wilkinson,et al.  Commentary: a physiological approach to hepatic drug clearance. , 1975, Clinical pharmacology and therapeutics.

[30]  Grant R. Wilkinson,et al.  A physiological approach to hepatic drug clearance , 1975 .

[31]  S. Haddad,et al.  Supplemental Analysis of the Prediction of Hepatic Clearance of Binary Mixtures of Bisphenol A and Naproxen Determined in an Isolated Perfused Rat Liver Model to Promote the Understanding of Potential Albumin-Facilitated Hepatic Uptake Mechanism. , 2017, Journal of pharmaceutical sciences.

[32]  J. Boyer,et al.  Effect of Albumin Binding on Extraction of Sulfobromophthalein by Perfused Elasmobranch Liver: Evidence for Dissociation‐Limited Uptake , 1984, Hepatology.

[33]  K. Maeda,et al.  Prediction of the Overall Renal Tubular Secretion and Hepatic Clearance of Anionic Drugs and a Renal Drug-Drug Interaction Involving Organic Anion Transporter 3 in Humans by In Vitro Uptake Experiments , 2011, Drug Metabolism and Disposition.

[34]  Y. Sawada,et al.  'Albumin-mediated transport phenomenon' observed for ligands with high membrane permeability. Effect of the unstirred water layer in the Disse's space of rat liver. , 1992, Journal of hepatology.

[35]  Tim Morris,et al.  Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.

[36]  K. Standing,et al.  Hepatocyte [3H]-palmitate uptake: effect of albumin surface charge modification. , 2001, Canadian journal of physiology and pharmacology.

[37]  M. Bogoyevitch,et al.  Uptake of palmitate by hepatocyte suspensions: facilitation by albumin? , 1992, The American journal of physiology.

[38]  A. Konstantinos,et al.  A Comparative Assessment , 2003 .

[39]  T Iwatsubo,et al.  PREDICTION OF IN VIVO DRUG DISPOSITION FROM IN VITRO DATA BASED ON PHYSIOLOGICAL PHARMACOKINETICS , 1996, Biopharmaceutics & drug disposition.

[40]  D. Meijer,et al.  Covalent and Noncovalent Protein Binding of Drugs: Implications for Hepatic Clearance, Storage, and Cell-Specific Drug Delivery , 1989, Pharmaceutical Research.

[41]  L. Kirshenbaum,et al.  Palmitate uptake by neonatal rat myocytes and hepatocytes. Role of extracellular protein. , 2001, European journal of biochemistry.